In a collaboration involving 41 hospitals in 18 countries, a team led by researchers at the University of Oxford has demonstrated that the Omicron variant of COVID-19 puts pregnant women at greater risk of severe illness and death, and that vaccination is effective in protecting against this.
A new paper from the UK Coronavirus Cancer Project has found that antibody testing is a valuable tool for identifying cancer patients most at risk of breakthrough COVID-19 infection.
New data from the PITCH study has shed new light on how well immune protection from COVID-19 lasts over time, and the value of booster vaccine doses in maintaining protection against infection.
A new vaccine developed by French pharmaceutical company Sanofi has been authorised for use in the UK after meeting required safety, quality and effectiveness standards.
A new study by a team from Imperial College London has shown that immune responses to the COVID-19 vaccine in people with chronic myeloid leukaemia treated with tyrosine kinase inhibitors are similar to those in people without the illness.
We caught up with Dr Eleanor Karp-Tatham, who has been driving the length and breadth of the country to collect samples for the COVIG study, which is examining the relation between a person’s genes and their immune response to the vaccines.
A group of researchers from the University of Edinburgh’s Usher Institute have shed new light on the safety of the COVID-19 vaccines in early pregnancy.
SIREN was established early on in the COVID-19 pandemic to monitor COVID-19 infections and the immune response in healthcare workers. We take a look at the story so far.